133 related articles for article (PubMed ID: 36053321)
1. [Organ preservation in patients with rectal cancer after total neoadjuvant treatment].
Germer CT; Reibetanz J
Chirurgie (Heidelb); 2022 Oct; 93(10):997-998. PubMed ID: 36053321
[No Abstract] [Full Text] [Related]
2. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
[TBL] [Abstract][Full Text] [Related]
3. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
4. Rectal perforation after neoadjuvant chemoradiotherapy for low-lying rectal cancer.
ElGendy K
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25564637
[No Abstract] [Full Text] [Related]
5. [Benefits and disadvantages of preoperative chemoradiotherapy for rectal cancer].
Konishi T; Ueno M; Fukunaga Y
Nihon Rinsho; 2016 Nov; 74(11):1857-1862. PubMed ID: 30550695
[TBL] [Abstract][Full Text] [Related]
6. Locally advanced rectal cancer: Preliminary results of rectal preservation after neoadjuvant chemoradiotherapy.
Vaccaro CA; Yazyi FJ; Ojra Quintana G; Santino JP; Sardi ME; Beder D; Tognelli J; Bonadeo F; Lastiri JM; Rossi GL
Cir Esp; 2016 May; 94(5):274-9. PubMed ID: 26980259
[TBL] [Abstract][Full Text] [Related]
7. The role of chemoradiotherapy in organ preservation for rectal cancer.
Xie L; Chen Q; Zhu J
Ann Oncol; 2023 Apr; 34(4):440. PubMed ID: 36549588
[No Abstract] [Full Text] [Related]
8. Comment on "Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy".
Kanemoto Y; Kurokawa T; Tanimoto T
Ann Surg; 2019 Dec; 270(6):e118-e119. PubMed ID: 31425284
[No Abstract] [Full Text] [Related]
9. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
[TBL] [Abstract][Full Text] [Related]
10. RE: Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
Bujko K; Rutkowski A
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27986886
[No Abstract] [Full Text] [Related]
11. Organ preservation in rectal cancer: towards the norm rather than the exception.
Roxburgh CS
Br J Surg; 2021 Jul; 108(7):745-747. PubMed ID: 34195801
[No Abstract] [Full Text] [Related]
12. [Total neoadjuvant therapy followed by watch and wait approach or organ preservation for MRI stratified low-risk rectal cancer: early result from a prospective, single arm trial].
Wang L; Zhao YM; Sun TT; Xu YL; Li SJ; Zhang XY; Cai Y; Li YH; Li ZW; Chen PJ; Peng YF; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):258-265. PubMed ID: 32192305
[No Abstract] [Full Text] [Related]
13. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients.
Mei SW; Liu Z; Wei FZ; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Pei W; Wang Z; Wang XS; Liu Q
World J Gastroenterol; 2020 Aug; 26(31):4624-4638. PubMed ID: 32884221
[TBL] [Abstract][Full Text] [Related]
14. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors of response to chemoradiotherapy for rectal cancer as an aid to organ preservation.
Fischer J; Eglinton TW; Frizelle FA
ANZ J Surg; 2021 Jun; 91(6):1190-1195. PubMed ID: 33404195
[TBL] [Abstract][Full Text] [Related]
16. Is organ preservation in rectal cancer ready for prime time?
Tekkis P; Tait D; Cunningham D; Brown G
Lancet; 2018 Jun; 391(10139):2480-2482. PubMed ID: 29976455
[No Abstract] [Full Text] [Related]
17. Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?
Fernandez LM; Figueiredo NL; Habr-Gama A; São Julião GP; Vieira P; Vailati BB; Nasir I; Parés O; Santiago I; Castillo-Martin M; Carvalho C; Parvaiz A; Perez RO
Dis Colon Rectum; 2020 Aug; 63(8):1053-1062. PubMed ID: 32692070
[TBL] [Abstract][Full Text] [Related]
18. Contact Radiation Therapy for Achieving Organ Preservation in Rectal Cancer After Standard Neoadjuvant Chemoradiation: Looking for a Place in the Sun.
Habr-Gama A; Perez RO
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):574-576. PubMed ID: 29413272
[No Abstract] [Full Text] [Related]
19. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
Rullier E; Rouanet P; Tuech JJ; Valverde A; Lelong B; Rivoire M; Faucheron JL; Jafari M; Portier G; Meunier B; Sileznieff I; Prudhomme M; Marchal F; Pocard M; Pezet D; Rullier A; Vendrely V; Denost Q; Asselineau J; Doussau A
Lancet; 2017 Jul; 390(10093):469-479. PubMed ID: 28601342
[TBL] [Abstract][Full Text] [Related]
20. Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial.
Gérard JP; Chamorey E; Gourgou-Bourgade S; Benezery K; de Laroche G; Mahé MA; Boige V; Juzyna B
Radiother Oncol; 2015 May; 115(2):246-52. PubMed ID: 25921382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
